| Features: |
| Zerumbone is a sesquiterpene α,β-unsaturated carbonyl compound derived primarily from Zingiber zerumbet (shampoo ginger). It is one of the most intensively studied dietary terpenoids for anticancer activity, with a strong and internally consistent mechanism-of-action profile across multiple cancer types.
Zerumbone induces intrinsic (mitochondrial) apoptosis via: -↑ ROS generation in cancer cells -Loss of mitochondrial membrane potential -↑ Bax / ↓ Bcl-2 and Bcl-xL -Cytochrome c release -Caspase-9 → caspase-3 activation Zerumbone is a potent NF-κB inhibitor Anti-angiogenic and anti-metastatic effects -Observed actions include: -↓ VEGF and HIF-1α -↓ MMP-2 / MMP-9 -Suppression of EMT markers (N-cadherin, vimentin) -Reduced migration and invasion Zerumbone is a redox-bifunctional agent: In cancer cells: -↑ ROS beyond survival threshold -Triggers mitochondrial collapse In normal cells: -Activates Nrf2 -Induces phase II detox enzymes (HO-1, NQO1, GST) This differential redox response explains selective toxicity. Bioavailability is limited |
| 4882- | ZER, | An update of Nrf2 activators and inhibitors in cancer prevention/promotion |
| - | Review, | Var, | NA |
| 4885- | ZER, | Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives |
| - | Review, | Var, | NA |
| 4886- | ZER, | Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratio |
| - | in-vitro, | Liver, | HepG2 |
| 4887- | ZER, | Rad, | Cisplatin, | Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma |
| - | in-vitro, | HNSCC, | CAL27 |
| 4888- | ZER, | 5-FU, | Modulation of the tumor microenvironment by zerumbone and 5-fluorouracil in colorectal cancer by target in cancer-associated fibroblasts |
| - | in-vitro, | CRC, | CT26 |
| 4889- | ZER, | Zerumbone reduces proliferation of HCT116 colon cancer cells by inhibition of TNF-alpha |
| - | in-vitro, | CRC, | HCT116 |
| - | in-vitro, | Nor, | RAW264.7 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:384 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid